vs
INDEPENDENCE REALTY TRUST, INC.（IRT）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是INDEPENDENCE REALTY TRUST, INC.的1.3倍（$207.3M vs $165.3M），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 2.5%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 2.2%）
独立房地产信托是一家专注于商业地产领域的不动产投资信托企业，投资布局覆盖费城、华盛顿特区以及得克萨斯州奥斯汀市的优质写字楼资产，为投资者创造稳定的不动产投资回报。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
IRT vs RARE — 直观对比
营收规模更大
RARE
是对方的1.3倍
$165.3M
营收增速更快
RARE
高出23.4%
2.5%
两年增速更快
RARE
近两年复合增速
2.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $165.3M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | 2.5% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $0.00 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRTRARE
| Q1 26 | $165.3M | — | ||
| Q4 25 | $167.1M | $207.3M | ||
| Q3 25 | $167.1M | $159.9M | ||
| Q2 25 | $162.2M | $166.5M | ||
| Q1 25 | $161.2M | $139.3M | ||
| Q4 24 | $161.0M | $164.6M | ||
| Q3 24 | $160.1M | $139.5M | ||
| Q2 24 | $158.4M | $147.0M |
净利润IRTRARE
| Q1 26 | — | — | ||
| Q4 25 | $33.3M | $-128.6M | ||
| Q3 25 | $6.9M | $-180.4M | ||
| Q2 25 | $8.0M | $-115.0M | ||
| Q1 25 | $8.4M | $-151.1M | ||
| Q4 24 | $-1.0M | $-133.2M | ||
| Q3 24 | $12.4M | $-133.5M | ||
| Q2 24 | $10.4M | $-131.6M |
营业利润率IRTRARE
| Q1 26 | — | — | ||
| Q4 25 | — | -54.7% | ||
| Q3 25 | — | -106.9% | ||
| Q2 25 | — | -64.8% | ||
| Q1 25 | — | -102.6% | ||
| Q4 24 | — | -74.3% | ||
| Q3 24 | — | -94.6% | ||
| Q2 24 | — | -79.1% |
净利率IRTRARE
| Q1 26 | — | — | ||
| Q4 25 | 19.9% | -62.0% | ||
| Q3 25 | 4.1% | -112.8% | ||
| Q2 25 | 5.0% | -69.0% | ||
| Q1 25 | 5.2% | -108.5% | ||
| Q4 24 | -0.6% | -80.9% | ||
| Q3 24 | 7.7% | -95.7% | ||
| Q2 24 | 6.5% | -89.5% |
每股收益（稀释后）IRTRARE
| Q1 26 | $0.00 | — | ||
| Q4 25 | $0.14 | $-1.28 | ||
| Q3 25 | $0.03 | $-1.81 | ||
| Q2 25 | $0.03 | $-1.17 | ||
| Q1 25 | $0.04 | $-1.57 | ||
| Q4 24 | $-0.01 | $-1.34 | ||
| Q3 24 | $0.05 | $-1.40 | ||
| Q2 24 | $0.05 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.3M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.4B | $-80.0M |
| 总资产 | $6.1B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRTRARE
| Q1 26 | $23.3M | — | ||
| Q4 25 | $23.6M | $421.0M | ||
| Q3 25 | $23.3M | $202.5M | ||
| Q2 25 | $19.5M | $176.3M | ||
| Q1 25 | $29.1M | $127.1M | ||
| Q4 24 | $21.2M | $174.0M | ||
| Q3 24 | $17.6M | $150.6M | ||
| Q2 24 | $21.0M | $480.7M |
总债务IRTRARE
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — |
股东权益IRTRARE
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.5B | $-80.0M | ||
| Q3 25 | $3.5B | $9.2M | ||
| Q2 25 | $3.4B | $151.3M | ||
| Q1 25 | $3.5B | $144.2M | ||
| Q4 24 | $3.4B | $255.0M | ||
| Q3 24 | $3.4B | $346.8M | ||
| Q2 24 | $3.4B | $432.4M |
总资产IRTRARE
| Q1 26 | $6.1B | — | ||
| Q4 25 | $6.0B | $1.5B | ||
| Q3 25 | $6.1B | $1.2B | ||
| Q2 25 | $6.0B | $1.3B | ||
| Q1 25 | $6.0B | $1.3B | ||
| Q4 24 | $6.1B | $1.5B | ||
| Q3 24 | $5.9B | $1.5B | ||
| Q2 24 | $5.9B | $1.6B |
负债/权益比IRTRARE
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.65× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 0.68× | — | ||
| Q2 24 | 0.66× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流IRTRARE
| Q1 26 | — | — | ||
| Q4 25 | $282.1M | $-99.8M | ||
| Q3 25 | $79.3M | $-91.4M | ||
| Q2 25 | $82.2M | $-108.3M | ||
| Q1 25 | $60.4M | $-166.5M | ||
| Q4 24 | $259.8M | $-79.3M | ||
| Q3 24 | $69.2M | $-67.0M | ||
| Q2 24 | $83.0M | $-77.0M |
自由现金流IRTRARE
| Q1 26 | — | — | ||
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M |
自由现金流率IRTRARE
| Q1 26 | — | — | ||
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% |
资本支出强度IRTRARE
| Q1 26 | — | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% |
现金转化率IRTRARE
| Q1 26 | — | — | ||
| Q4 25 | 8.48× | — | ||
| Q3 25 | 11.51× | — | ||
| Q2 25 | 10.22× | — | ||
| Q1 25 | 7.23× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.60× | — | ||
| Q2 24 | 8.02× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRT
| Rental and other property revenue | $165.2M | 100% |
| Other revenue | $109.0K | 0% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
